← Open Payments lookup

CATHERINE DOTY: Open Payments

NPI 1316015696 · NEWPORT, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,615 in 64 payments from 14 companies in 2025. Trend: 2023 $2,636 · 2024 $1,488 · 2025 $1,615

Food & beverage: $1,615
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$509
Axsome Therapeutics, Inc.9$135
Neurocrine BioSciences, Inc.5$132
Alkermes, Inc.5$132
Lundbeck LLC4$108
Otsuka America Pharmaceutical, Inc.5$108
E.R. Squibb & Sons, L.L.C.4$100
Janssen Pharmaceuticals, Inc4$86
Vanda Pharmaceuticals Inc.4$85
Tris Pharma Inc4$68

Products named: CAPLYTA, REXULTI, INGREZZA, LYBALVI, Auvelity, COBENFY, Dyanavel XR, HETLIOZ.

Industry payments across DE — which companies pay providers there.